The two types of combination efficiently stratified CRC patients with distinct prognosis in the same cohort and exhibited stronger stratification power than the single markers did (Supplementary Table S2), indicating that the discriminating effect of SHP2 and STAT3 in predicting CRC prognosis was complementary. The gene discussed is PTPN11; the disease is colorectal carcinoma.